UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 37

Sortiert nach

221 NEW CUTOFF VALUES FOR SARCOPENIA FOR PREDICTING 6-MONTH MORTALITY IN CIRRHOTIC PATIENTS

Journal of hepatology, 2013-04, Vol.58, p.S95-S95

2013

Volltextzugriff (PDF)

Cardiac management during adjuvant trastuzumab therapy: recommendations of the Canadian Trastuzumab Working Group

Current oncology (Toronto), 2008, Vol.15 (1), p.24-35

2008

Volltextzugriff (PDF)

732 SARCOPENIA IS ASSOCIATED WITH MORTALITY IN PATIENTS WITH CIRRHOSIS AND HEPATOCELLULAR CARCINOMA

Journal of hepatology, 2012-04, Vol.56, p.S288-S289

2012

Volltextzugriff (PDF)

Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142

Annals of oncology, 2022-10, Vol.33 (10), p.1052-1060

2022

Volltextzugriff (PDF)

Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma

Annals of oncology, 2010-08, Vol.21 (8), p.1594-1598

2010

Volltextzugriff (PDF)

A phase I dose escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer

Annals of oncology, 2014-09, Vol.25 (9), p.1750-1755

2014

Volltextzugriff (PDF)

1051P Impacts of skeletal muscle on survival in resected stage III malignant melanoma

Annals of oncology, 2021-09, Vol.32, p.S878-S879

2021

Volltextzugriff (PDF)

Efficacy of pancreatic enzyme replacement therapy for muscle mass maintenance is dose dependent in patients with advanced pancreatic cancer

Clinical nutrition ESPEN, 2023-12, Vol.58, p.708-709

2023

Volltextzugriff (PDF)

Nutritional cancer care: Slowly evolving clinical practice reveals regional and professional HCP variability

Annals of oncology, 2018-10, Vol.29, p.viii618-viii618

2018

Volltextzugriff (PDF)

173 Synergistic toxicity of tyrosine kinase inhibitors with Hsp90 inhibitor 17-AAG in lung cancer cell line

European journal of cancer supplements, 2010, Vol.8 (7), p.59-60

2010

Volltextzugriff (PDF)

A phase I study to determine the safety, pharmacokinetics and pharmacodynamics of a dual VEGFR and FGFR inhibitor, brivanib, in patients with advanced or metastatic solid tumors

Annals of oncology, 2011-06, Vol.22 (6), p.1413-1419

2011

Volltextzugriff (PDF)

Dietary Protein As A Therapy To Prevent Low Muscle Mass In Cancer: Preliminary Findings From The Prime Study

Clinical nutrition ESPEN, 2023-04, Vol.54, p.589-590

2023

Volltextzugriff (PDF)

Total 24-Hour Energy Expenditure Measured By Calorimetry Chamber In Patients With Colorectal Cancer: Baseline Findings From The Prime Study

Clinical nutrition ESPEN, 2023-04, Vol.54, p.588-589

2023

Volltextzugriff (PDF)

Comparing dietary intake at cancer diagnosis to recommendations and actual need

Clinical nutrition ESPEN, 2020-12, Vol.40, p.664-664

2020

Volltextzugriff (PDF)

P005 N-3 POLYUNSATURATED FATTY ACIDS’ DUAL MODULATORY EFFECTS ON SYSTEMIC AND INTESTINAL IMMUNITY IN TUMOR-BEARING RATS RECEIVING DOSE-INTENSIVE CPT-11 CHEMOTHERAPY

Clinical nutrition. Supplements, 2009, Vol.4 (2), p.27-27

2009

Volltextzugriff (PDF)

Feasibility of two levels of protein intake in patients with colorectal cancer: findings from the Protein Recommendation to Increase Muscle (PRIMe) randomized controlled pilot trial

ESMO open, 2024-07, Vol.9 (7), p.103604, Article 103604

2024

Volltextzugriff (PDF)

A phase 1 study evaluating the pharmacokinetics (PK) and safety of regorafenib (REG) in patients with advanced solid tumors with severe renal impairment (SRI)

Annals of oncology, 2016-10, Vol.27, p.vi167-vi167

2016

Volltextzugriff (PDF)

Benefits, issues, and recommendations for personalized medicine in oncology in Canada

Current oncology (Toronto), 2013-10, Vol.20 (5), p.e475-483

2013

Volltextzugriff (PDF)

A Phase 1B Study of Brivanib in Combination with 5FU/LV and FOLFIRI in Patients with Advanced or Metastatic Gastro-Intestinal Malignancies

Annals of oncology, 2013-03, Vol.24, p.i33-i33

2013

Volltextzugriff (PDF)

Prediction of body composition in elderly men over 75 years of age

Annals of human biology, 1996, Vol.23 (2), p.127-147

1996

Volltextzugriff (PDF)

Energy expenditure using isotope-labelled water (2H2180), exercise performance, skeletal muscle enzyme activities and plasma biochemical parameters in humans during 95 days of endurance exercise with inadequate energy intake

European journal of applied physiology, 1997, Vol.76 (3), p.243-252

1997

Volltextzugriff (PDF)

Longitudinal assessment of the components of energy balance in well-nourished lactating women

The American journal of clinical nutrition, 1991-11, Vol.54 (5), p.788-798

1991

Volltextzugriff (PDF)

Bias between two reference methods of body composition assessment in elderly men

Clinical nutrition (Edinburgh, Scotland), 1994, Vol.13, p.38-38

1994

Volltextzugriff (PDF)

Whole-body albumin mass and distribution in rats fed on low-protein diets

British journal of nutrition, 1977-01, Vol.37 (1), p.127-134

1977

Volltextzugriff (PDF)

Microtechniques for the automated analysis of serum total protein and albumin, urinary urea, creatinine, and hydroxyproline for nutrition surveys in developing countries

The American journal of clinical nutrition, 1971-08, Vol.24 (8), p.940-946

1971

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(37)

Sprache

Englisch
(37)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(16)
Life Sciences & Biomedicine
(14)
Humans
(9)
Oncology
(7)
Female
(6)
Male
(6)
Biological And Medical Sciences
(5)
Nutrition & Dietetics
(5)
Aged
(4)
Body Composition
(4)
Middle Aged
(4)
Adult
(3)
Animals
(3)
Antineoplastic Agents
(3)
Gastroenterology And Hepatology
(3)
Human Nutrition
(3)
Medical Sciences
(3)
Pharmacology. Drug Treatments
(3)
Aged, 80 And Over
(2)
Antineoplastic Agents - Therapeutic Use
(2)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

221 NEW CUTOFF VALUES FOR SARCOPENIA FOR PREDICTING 6-MONTH MORTALITY IN CIRRHOTIC PATIENTS

Cardiac management during adjuvant trastuzumab therapy: recommendations of the Canadian Trastuzumab Working Group

732 SARCOPENIA IS ASSOCIATED WITH MORTALITY IN PATIENTS WITH CIRRHOSIS AND HEPATOCELLULAR CARCINOMA

Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142

Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma

A phase I dose escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer

1051P Impacts of skeletal muscle on survival in resected stage III malignant melanoma

Efficacy of pancreatic enzyme replacement therapy for muscle mass maintenance is dose dependent in patients with advanced pancreatic cancer

Nutritional cancer care: Slowly evolving clinical practice reveals regional and professional HCP variability

173 Synergistic toxicity of tyrosine kinase inhibitors with Hsp90 inhibitor 17-AAG in lung cancer cell line

A phase I study to determine the safety, pharmacokinetics and pharmacodynamics of a dual VEGFR and FGFR inhibitor, brivanib, in patients with advanced or metastatic solid tumors

Dietary Protein As A Therapy To Prevent Low Muscle Mass In Cancer: Preliminary Findings From The Prime Study

Total 24-Hour Energy Expenditure Measured By Calorimetry Chamber In Patients With Colorectal Cancer: Baseline Findings From The Prime Study

Comparing dietary intake at cancer diagnosis to recommendations and actual need

P005 N-3 POLYUNSATURATED FATTY ACIDS’ DUAL MODULATORY EFFECTS ON SYSTEMIC AND INTESTINAL IMMUNITY IN TUMOR-BEARING RATS RECEIVING DOSE-INTENSIVE CPT-11 CHEMOTHERAPY

Feasibility of two levels of protein intake in patients with colorectal cancer: findings from the Protein Recommendation to Increase Muscle (PRIMe) randomized controlled pilot trial

A phase 1 study evaluating the pharmacokinetics (PK) and safety of regorafenib (REG) in patients with advanced solid tumors with severe renal impairment (SRI)

Benefits, issues, and recommendations for personalized medicine in oncology in Canada

A Phase 1B Study of Brivanib in Combination with 5FU/LV and FOLFIRI in Patients with Advanced or Metastatic Gastro-Intestinal Malignancies

Prediction of body composition in elderly men over 75 years of age

Energy expenditure using isotope-labelled water (2H2180), exercise performance, skeletal muscle enzyme activities and plasma biochemical parameters in humans during 95 days of endurance exercise with inadequate energy intake

Longitudinal assessment of the components of energy balance in well-nourished lactating women

Bias between two reference methods of body composition assessment in elderly men

Whole-body albumin mass and distribution in rats fed on low-protein diets

Microtechniques for the automated analysis of serum total protein and albumin, urinary urea, creatinine, and hydroxyproline for nutrition surveys in developing countries

Suchergebnisse filtern